A novel marker of inflammation in patients with slow coronary flow: lymphocyte-to-monocyte ratio

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries – a new angiographic finding. Am. Heart. J. 84(1), 66–71 (1972). • This was the first study that identified the slow coronary flow (SCF).
  Medline CASGoogle Scholar
• 2 Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology 52(8), 507–514 (2001).
  Medline CASGoogle Scholar
• 3 Gokce M, Kaplan S, Tekelioglu Y, Erdogan T, Kucukosmanoglu M. Platelet function disorder in patients with coronary slow flow. Clin. Cardiol. 28(3), 145–148 (2005).
  MedlineGoogle Scholar
• 4 Li JJ, Xu B, Li ZC, Qian J, Wei BQ. Is slow coronary flow associated with inflammation? Med. Hypotheses 66(3), 504–508 (2006). • Showed that inflammation related with SCF.
  MedlineGoogle Scholar
• 5 Dogan M, Akyel A, Cimen T et al. Relationship between neutrophil to lymphocyte ratio and slow coronary flow. Clin. Appl. Thromb. Hemost. 21(3), 251–254 (2015). • This was the first study that neutrophil-to-lymphocyte ratio related with SCF.
  MedlineGoogle Scholar
• 6 Turhan H, Saydam GS, Erbay AR et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int. J. Cardiol. 108(2), 224–230 (2006).
  MedlineGoogle Scholar
• 7 Horne BD, Anderson JL, John JM et al. Which white blood cell subtypes predict increased cardiovascular risk? J. Am. Coll. Cardiol. 45(10), 1638–1643 (2005).
  MedlineGoogle Scholar
• 8 Nunez J, Minana G, Bodi V et al. Low lymphocyte count and cardiovascular diseases. Curr. Med. Chem. 18(21), 3226–3233 (2011).
  Medline CASGoogle Scholar
• 9 Van Der Laan AM, Hirsch A, Robbers LF et al. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction. Am. Heart. J. 163(1), 57 e52–65 e52 (2012).
  Google Scholar
• 10 Maekawa Y, Anzai T, Yoshikawa T et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J. Am. Coll. Cardiol. 39(2), 241–246 (2002). • Showed that monocytosis associated with atherosclerotic coronary disease.
  MedlineGoogle Scholar
• 11 Hu P, Shen H, Wang G, Zhang P, Liu Q, Du J. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study. PLoS ONE 9(9), e108062 (2014).
  MedlineGoogle Scholar
• 12 Han LH, Jia YB, Song QX, Wang JB, Wang NN, Cheng YF. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma. Asian Pac. J. Cancer Prev. 16(6), 2245–2250 (2015).
  MedlineGoogle Scholar
• 13 Murat SN, Yarlioglues M, Celik IE et al. The Relationship between lymphocyte-to-monocyte ratio and bare-metal stent in-stent restenosis in patients with stable coronary artery disease. Clin. Appl. Thromb. Hemost. doi:10.1177/1076029615627340 (2016) (Epub ahead of print). •• This was the first study demonstrating lymphocyte-to-monocyte ratio as a prognostic marker of cardiovascular events in patients with stable coronary artery disease.
  Google Scholar
• 14 Kurtul A, Yarlioglues M, Celik IE et al. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron. Artery. Dis. 26(8), 706–712 (2015).
  MedlineGoogle Scholar
• 15 Gibson CM, Cannon CP, Daley WL et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93(5), 879–888 (1996).
  Medline CASGoogle Scholar
• 16 Stone GW, Brodie BR, Griffin JJ et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J. Am. Coll. Cardiol. 31(1), 23–30 (1998).
  Medline CASGoogle Scholar
• 17 Xu Y, Meng HL, Su YM et al. Serum YKL-40 is increased in patients with slow coronary flow. Coron. Artery. Dis. 26(2), 121–125 (2015).
  MedlineGoogle Scholar
• 18 Cetin MS, Ozcan Cetin EH, Canpolat U et al. An overlooked parameter in coronary slow flow phenomenon: whole blood viscosity. Biomark. Med. 9(12), 1311–1321 (2015).
  CASGoogle Scholar
• 19 Hutterer GC, Sobolev N, Ehrlich GC et al. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma. J. Clin. Pathol. 68(5), 351–355 (2015).
  MedlineGoogle Scholar
• 20 Yue S, Zhang J, Wu J, Teng W, Liu L, Chen L. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int. J. Environ. Res. Public. Health. 12(8), 10009–10019 (2015).
  Medline CASGoogle Scholar
• 21 Gary T, Pichler M, Belaj K et al. Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. Int. J. Clin. Pract. 68(12), 1483–1487 (2014).
  Medline CASGoogle Scholar
• 22 Kounis NG, Hahalis G. White blood cell counts in predicting cardiovascular events: the racial ratios. Coron. Artery. Dis. 26(5), 369–371 (2015).
  MedlineGoogle Scholar
• 23 Kounis NG, Soufras GD, Tsigkas G, Hahalis G. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease. Clin. Appl. Thromb. Hemost. 21(2), 139–143 (2015).
  MedlineGoogle Scholar
• 24 Widmer A, Linka AZ, Attenhofer Jost CH et al. Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia. Cardiology 99(1), 25–31 (2003).
  Medline CASGoogle Scholar
• 25 Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am. J. Cardiol. 79(6), 812–814 (1997).
  Medline CASGoogle Scholar
• 26 Ommen SR, Hodge DO, Rodeheffer RJ, Mcgregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97(1), 19–22 (1998).
  Medline CASGoogle Scholar
• 27 Mohler ER 3rd. Mechanisms of aortic valve calcification. Am. J. Cardiol. 94(11), 1396–1402 (2004).
  MedlineGoogle Scholar
• 28 Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int. J. Cardiol. 130(2), 147–158 (2008).
  MedlineGoogle Scholar
• 29 Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY. The CD14⁺+CD16⁺ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J. Thromb. Haemost. 10(7), 1231–1241 (2012).
  Medline CASGoogle Scholar